Literature DB >> 23369757

Chronic high levels of the RCAN1-1 protein may promote neurodegeneration and Alzheimer disease.

Gennady Ermak1, Kelvin J A Davies2.   

Abstract

The RCAN1 gene encodes three different protein isoforms: RCAN1-4, RCAN1-1L, and RCAN1-1S. RCAN1-1L is the RCAN1 isoform predominantly expressed in human brains. RCAN1 proteins have been shown to regulate various other proteins and cellular functions, including calcineurin, glycogen synthase kinase-3β (GSK-3β), the mitochondrial adenine nucleotide transporter (ANT), stress adaptation, ADP/ATP exchange in mitochondria, and the mitochondrial permeability transition pore (mtPTP). The effects of increased RCAN1 gene expression seem to depend both on the specific RCAN1 protein isoform(s) synthesized and on the length of time the level of each isoform is elevated. Transiently elevated RCAN1-4 and RCAN1-1L protein levels, lasting just a few hours, can be neuroprotective under acute stress conditions, including acute oxidative stress. We propose that, by transiently inhibiting the phosphatase calcineurin, RCAN1-4 and RCAN1-1L may reinforce and extend protective stress-adaptive cell responses. In contrast, prolonged elevation of RCAN1-1L levels is associated with the types of neurodegeneration observed in several diseases, including Alzheimer disease and Down syndrome. RCAN1-1L levels can also be increased by multiple chronic stresses and by glucocorticoids, both of which can cause neurodegeneration. Although increasing levels of RCAN1-1L for just a few months has no overtly obvious neurodegenerative effect, it does suppress neurogenesis. Longer term elevation of RCAN1-1L levels (for at least 16 months), however, can lead to the first signs of neurodegeneration. Such neurodegeneration may be precipitated by (RCAN1-1L-mediated) prolonged calcineurin inhibition and GSK-3β induction/activation, both of which promote tau hyperphosphorylation, and/or by (RCAN1-1L-mediated) effects on the mitochondrial ANT, diminished ATP/ADP ratio, opening of the mtPTP, and mitochondrial autophagy. We propose that RCAN1-1L operates through various molecular mechanisms, primarily dependent upon the length of time protein levels are elevated. We also suggest that models analyzing long-term RCAN1 gene overexpression may help us to understand the molecular mechanisms of neurodegeneration in diseases such as Alzheimer disease, Down syndrome, and possibly others.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  (mitochondrial) adenine nucleotide transporter; ANT; Alzheimer disease; Free radicals; GSK-3β; Mitochondria; Neurodegeneration; Oxidative stress; RCAN1; glycogen synthase kinase-3β; mitochondrial permeability transition pore; mtPTP; regulator of calcineurin 1

Mesh:

Substances:

Year:  2013        PMID: 23369757      PMCID: PMC4720382          DOI: 10.1016/j.freeradbiomed.2013.01.016

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  52 in total

1.  Multiple oxidative stress-response members of the Adapt78 family.

Authors:  Henry J Michtalik; Ananth V Narayan; Nishant Bhatt; H Y Lin; Michael T Mulligan; Shen Li Zhang; Dana R Crawford
Journal:  Free Radic Biol Med       Date:  2004-08-15       Impact factor: 7.376

Review 2.  Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection.

Authors:  Sabzali Javadov; Morris Karmazyn
Journal:  Cell Physiol Biochem       Date:  2007

3.  Hamster adapt78 mRNA is a Down syndrome critical region homologue that is inducible by oxidative stress.

Authors:  D R Crawford; K P Leahy; N Abramova; L Lan; Y Wang; K J Davies
Journal:  Arch Biochem Biophys       Date:  1997-06-01       Impact factor: 4.013

4.  Proneness to psychological distress and risk of Alzheimer disease in a biracial community.

Authors:  R S Wilson; L L Barnes; D A Bennett; Y Li; J L Bienias; C F Mendes de Leon; D A Evans
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

5.  The DSCR1 (Adapt78) isoform 1 protein calcipressin 1 inhibits calcineurin and protects against acute calcium-mediated stress damage, including transient oxidative stress.

Authors:  Gennady Ermak; Cathryn D Harris; Kelvin J A Davies
Journal:  FASEB J       Date:  2002-06       Impact factor: 5.191

6.  DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways.

Authors:  J J Fuentes; L Genescà; T J Kingsbury; K W Cunningham; M Pérez-Riba; X Estivill; S de la Luna
Journal:  Hum Mol Genet       Date:  2000-07-01       Impact factor: 6.150

7.  Direct biomechanical induction of endogenous calcineurin inhibitor Down Syndrome Critical Region-1 in cardiac myocytes.

Authors:  Yanlin Wang; Gilles W De Keulenaer; Ellen O Weinberg; Suphi Muangman; Antonio Gualberto; Katherine T Landschulz; Thomas G Turi; John F Thompson; Richard T Lee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-08       Impact factor: 4.733

8.  Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque.

Authors:  J Jacob Kulstad; Pamela J McMillan; James B Leverenz; David G Cook; Pattie S Green; Elaine R Peskind; Charles W Wilkinson; Wesley Farris; Pankaj D Mehta; Suzanne Craft
Journal:  J Neuropathol Exp Neurol       Date:  2005-02       Impact factor: 3.685

9.  Renaming the DSCR1/Adapt78 gene family as RCAN: regulators of calcineurin.

Authors:  Kelvin J A Davies; Gennady Ermak; Beverley A Rothermel; Melanie Pritchard; Joseph Heitman; Joohong Ahnn; Flavio Henrique-Silva; Dana Crawford; Silvia Canaider; Pierluigi Strippoli; Paolo Carinci; Kyung-Tai Min; Deborah S Fox; Kyle W Cunningham; Rhonda Bassel-Duby; Eric N Olson; Zhuohua Zhang; R Sanders Williams; Hans-Peter Gerber; Mercè Pérez-Riba; Hisao Seo; Xia Cao; Claude B Klee; Juan Miguel Redondo; Lois J Maltais; Elspeth A Bruford; Sue Povey; Jeffery D Molkentin; Frank D McKeon; Elia J Duh; Gerald R Crabtree; Martha S Cyert; Susana de la Luna; Xavier Estivill
Journal:  FASEB J       Date:  2007-06-26       Impact factor: 5.191

10.  Phosphorylation of calcipressin 1 increases its ability to inhibit calcineurin and decreases calcipressin half-life.

Authors:  Lali Genescà; Anna Aubareda; Juan J Fuentes; Xavier Estivill; Susana De La Luna; Mercè Pérez-Riba
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

View more
  12 in total

1.  Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) Targets Down Syndrome Candidate Region 1 (DSCR1/RCAN1) to control Neuronal Differentiation.

Authors:  Eun Hye Lee; Seon Sook Kim; Seul Lee; Kwan-Hyuck Baek; Su Ryeon Seo
Journal:  J Biol Chem       Date:  2015-07-08       Impact factor: 5.157

2.  1H, 15N, and 13C chemical shift assignments of the regulatory domain of human calcineurin.

Authors:  Dinesh K Yadav; Sri Ramya Tata; John Hunt; Erik C Cook; Trevor P Creamer; Nicholas C Fitzkee
Journal:  Biomol NMR Assign       Date:  2017-08-12       Impact factor: 0.746

Review 3.  The Oxygen Paradox, the French Paradox, and age-related diseases.

Authors:  Joanna M S Davies; Josiane Cillard; Bertrand Friguet; Enrique Cadenas; Jean Cadet; Rachael Cayce; Andrew Fishmann; David Liao; Anne-Laure Bulteau; Frédéric Derbré; Amélie Rébillard; Steven Burstein; Etienne Hirsch; Robert A Kloner; Michael Jakowec; Giselle Petzinger; Delphine Sauce; Florian Sennlaub; Isabelle Limon; Fulvio Ursini; Matilde Maiorino; Christina Economides; Christian J Pike; Pinchas Cohen; Anne Negre Salvayre; Matthew R Halliday; Adam J Lundquist; Nicolaus A Jakowec; Fatima Mechta-Grigoriou; Mathias Mericskay; Jean Mariani; Zhenlin Li; David Huang; Ellsworth Grant; Henry J Forman; Caleb E Finch; Patrick Y Sun; Laura C D Pomatto; Onnik Agbulut; David Warburton; Christian Neri; Mustapha Rouis; Pierre Cillard; Jacqueline Capeau; Jean Rosenbaum; Kelvin J A Davies
Journal:  Geroscience       Date:  2017-12-21       Impact factor: 7.713

4.  Glucocorticoid-mediated co-regulation of RCAN1-1, E4BP4 and BIM in human leukemia cells susceptible to apoptosis.

Authors:  G Jonatan Saenz; Rebeka Hovanessian; Andrew D Gisis; Rheem D Medh
Journal:  Biochem Biophys Res Commun       Date:  2015-06-20       Impact factor: 3.575

Review 5.  Human Models Are Needed for Studying Human Neurodevelopmental Disorders.

Authors:  Xinyu Zhao; Anita Bhattacharyya
Journal:  Am J Hum Genet       Date:  2018-12-06       Impact factor: 11.025

6.  Protein profiles associated with context fear conditioning and their modulation by memantine.

Authors:  Md Mahiuddin Ahmed; A Ranjitha Dhanasekaran; Aaron Block; Suhong Tong; Alberto C S Costa; Katheleen J Gardiner
Journal:  Mol Cell Proteomics       Date:  2014-01-27       Impact factor: 5.911

7.  Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain.

Authors:  Marzia Perluigi; Gilda Pupo; Antonella Tramutola; Chiara Cini; Raffaella Coccia; Eugenio Barone; Elizabeth Head; D Allan Butterfield; Fabio Di Domenico
Journal:  Biochim Biophys Acta       Date:  2014-04-13

8.  The regulator of calcineurin 1 increases adenine nucleotide translocator 1 and leads to mitochondrial dysfunctions.

Authors:  Hui Jiang; Chen Zhang; Yu Tang; Juan Zhao; Tan Wang; Heng Liu; Xiulian Sun
Journal:  J Neurochem       Date:  2016-12-20       Impact factor: 5.372

Review 9.  Regulator of Calcineurin (RCAN): Beyond Down Syndrome Critical Region.

Authors:  Sun-Kyung Lee; Joohong Ahnn
Journal:  Mol Cells       Date:  2020-08-31       Impact factor: 5.034

10.  A semi-automated motion-tracking analysis of locomotion speed in the C. elegans transgenics overexpressing beta-amyloid in neurons.

Authors:  Kevin Machino; Christopher D Link; Susan Wang; Hana Murakami; Shin Murakami
Journal:  Front Genet       Date:  2014-07-04       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.